Published in Women's Health Weekly, January 22nd, 2000
These findings could prove significant in reducing risk factors associated with heart disease in women. Sponsored by the US National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI), the Women's Ischemia Syndrome Evaluation (WISE) is a multifaceted, 4-year,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.